"The Report Evonik
Corporation - Product Pipeline Analysis, 2016 Update provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Evonik Corporation (Evonik Corp),
formerly known as Evonik Degussa Corporation, a subsidiary of
subsidiary of Evonik Industries AG, manufacturer and supplier
specialty chemicals. The company has categorized its product
segments, namely, nutrition and care segment whose products can be
used in consumer, animal nutrition and health care ; resource
efficiency offers environment friendly and energy-efficient system
solutions; and performance materials offers polymer material and
intermediates for rubber and plastics industries. Its product
portfolio includes polymers, monomers, amino acid, silica, rubber and
others advanced chemicals. It has manufacturing facilities,
laboratories and distribution centers located across North America.
The companys products are used in various markets such as automotive,
metals and mining; oil and gas; transportation, printing, paints and
coatings; plastics, pharmaceuticals, and other industries. Evonik
Corp is headquartered in Parsippany, New Jersey, the US.
This report is a source for data,
analysis, and actionable intelligence on the companys portfolio of
pipeline products. The report provides key information about the
company, its major products and brands.
The report enhances decision
making capabilities and help to create effective counter strategies
to gain competitive advantage.
View Report @
http://www.marketresearchreports.biz/analysis/954997
Scope:
- The report reviews detailed
company profile with information on business description, key company
facts, major products and services, key competitors, key employees,
locations and subsidiaries and recent developments
- The report analyzes all pipeline
products in development for the company Evonik Corporation
- The report provides pipeline
analysis on all pipeline products of the company (by equipment type,
by indication, by development stage, and by trial status)
- The report covers detailed
information on each pipeline product with information on pipeline
territory, stage of development, device class, regulatory path,
indication(s), application(s) and estimated launch date
- The report provides detailed
description of products in development, technical specification and
functions
- The report also covers ongoing
clinical trials (wherever applicable) with information on trial name,
trial objective, sponsor, trial design , trial status and phase,
estimated start and end date.
Reasons to Buy:
- Develop business strategies by
understanding the trends and developments driving the medical devices
pipeline and technology landscape
- Design and develop your product
development, marketing and sales strategies by understanding the
competitor portfolio
- To formulate effective Research
& Development strategies
- Develop market-entry and market
expansion strategies
- Exploit in-licensing and
out-licensing opportunities by identifying products, most likely to
ensure a robust return
- Plan mergers and acquisitions
effectively by identifying key players of the most promising pipeline
- Identify emerging players with
potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Develop competition strategies
by identifying the status and likely launch of the competitors
pipeline products through review of the clinical trials, stage and of
development, etc
- Identify, understand and
capitalize the next high-value products that your competitor would
add in its portfolio
Read our latest Press Release
at http://www.marketresearchreports.biz/pressreleases
Table
of Contents
Table
of Contents 2
List
of Tables 3
List
of Figures 3
Evonik
Corporation Company Overview 4
Evonik
Corporation Company Snapshot 4
Evonik
Corporation Pipeline Products and Clinical Trials Overview 4
Evonik
Corporation Pipeline Analysis Overview 7
Key
Facts 7
Evonik
Corporation - Major Products and Services 8
Evonik
Corporation Pipeline Products by Development Stage 9
Evonik
Corporation Pipeline Products Overview 11
Cardiovascular
PEEK Implant 11
Cardiovascular
PEEK Implant Product Overview 11
Dental
PEEK Implant 12
Dental
PEEK Implant Product Overview 12
Neuromodulation
PEEK Implant 13
Neuromodulation
PEEK Implant Product Overview 13
PEEK
Implant - Sleep Apnea 14
PEEK
Implant - Sleep Apnea Product Overview 14
VESTAKEEP
PEEK With Barium Sulfate (BaSO4) 15
VESTAKEEP
PEEK With Barium Sulfate (BaSO4) Product Overview 15
VESTAKEEP
PEEK With Carbon Fiber (CFF) 16
VESTAKEEP
PEEK With Carbon Fiber (CFF) Product Overview 16
Evonik
Corporation - Key Competitors 17
Evonik
Corporation - Key Employees 18
Evonik
Corporation - Locations And Subsidiaries 19
Head
Office 19
Other
Locations & Subsidiaries 19
Recent
Developments 21
Evonik
Corporation, Recent Developments 21
Apr
05, 2016: MedTec 2016: Evonik is raising the bar in the dental sector
with VESTAKEEP PEEK 21
Feb
29, 2016: Evoniks VESTAKEEP PEEK Validated by Surface Dynamics for
Titanium Coating 21
Jan
28, 2016: Arthroscopy implants made from VESTAKEEP PEEK are now CE
approved 22
Sep
22, 2015: C4 Imaging Utilizes Evonik's VESTAKEEP PEEK For Prostate
Cancer Device 22
Mar
10, 2014: Evonik Reaches Milestone with Permanently Implantable
Vestakeep PEEK 23
Jan
17, 2014: New suture anchor made of VESTAKEEP PEEK 23
Feb
08, 2013: Evonik Receives FDA 510(k) Approval For Implantable
Vestakeep PEEK 24
Appendix
25
Methodology
25
About
GlobalData 25
Contact
Us 25
Disclaimer
25
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment